INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹672 Cr | ₹765 Cr | ₹687 Cr | ₹564 Cr | ₹428 Cr |
What is the latest Profit & Loss Account Balance ratio of INDOCO REMEDIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹672 Cr |
| Mar2024 | ₹765 Cr |
| Mar2023 | ₹687 Cr |
| Mar2022 | ₹564 Cr |
| Mar2021 | ₹428 Cr |
How is Profit & Loss Account Balance of INDOCO REMEDIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹672 Cr | -12.08 | |
| Mar2024 | ₹765 Cr | 11.32 | |
| Mar2023 | ₹687 Cr | 21.81 | |
| Mar2022 | ₹564 Cr | 31.68 | |
| Mar2021 | ₹428 Cr | - | |
Compare Profit & Loss Account Balance of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,935.1 Cr | 5% | -0.9% | -16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 5% |
-0.9% |
-16.2% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses